Materialise NV

NasdaqGS MTLS

Materialise NV Price to Book Ratio (P/B) on December 30, 2024: 1.59

Materialise NV Price to Book Ratio (P/B) is 1.59 on December 30, 2024, a 14.83% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Materialise NV 52-week high Price to Book Ratio (P/B) is 1.89 on December 12, 2024, which is 18.87% above the current Price to Book Ratio (P/B).
  • Materialise NV 52-week low Price to Book Ratio (P/B) is 1.08 on July 03, 2024, which is -31.92% below the current Price to Book Ratio (P/B).
  • Materialise NV average Price to Book Ratio (P/B) for the last 52 weeks is 1.29.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
NasdaqGS: MTLS

Materialise NV

CEO Ms. Brigitte de Vet-Veithen
IPO Date June 25, 2014
Location Belgium
Headquarters Technologielaan 15
Employees 2,437
Sector Technology
Industries
Description

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Similar companies

CWAN

Clearwater Analytics Holdings, Inc.

USD 26.45

2.12%

ADEA

Adeia Inc.

USD 12.87

1.42%

ONTF

ON24, Inc.

USD 6.32

2.10%

EXFY

Expensify, Inc.

USD 3.18

0.32%

VTEX

VTEX

USD 5.95

2.23%

LAW

CS Disco, Inc.

USD 4.96

1.02%

ENFN

Enfusion, Inc.

USD 10.81

0.00%

CCRD

CoreCard Corporation

USD 22.62

0.76%

MLNK

MeridianLink, Inc.

USD 18.95

-0.32%

StockViz Staff

January 15, 2025

Any question? Send us an email